188 related articles for article (PubMed ID: 38073586)
1. circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma.
Liu Y; Chen K; Shou Y; Li S; Wang J; Zhang Q; Huang Z; Xu J; Li M; Liu D; Liang H; Yang H; Zhang X
Clin Transl Med; 2023 Dec; 13(12):e1512. PubMed ID: 38073586
[TBL] [Abstract][Full Text] [Related]
2.
Gu Y; Niu S; Wang Y; Duan L; Pan Y; Tong Z; Zhang X; Yang Z; Peng B; Wang X; Han X; Li Y; Cheng T; Liu Y; Shang L; Liu T; Yang X; Sun M; Jiang S; Zhang C; Zhang N; Ye Q; Gao S
Cancer Res; 2021 Feb; 81(4):923-934. PubMed ID: 33293428
[TBL] [Abstract][Full Text] [Related]
3.
Zhao A; Wang Y; Wang Z; Shao Q; Gong QI; Zhu H; Shen S; Liu HU; Chen X
Oncol Res; 2024; 32(5):983-998. PubMed ID: 38686044
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA, circular RARS, promotes aerobic glycolysis of non-small-cell lung cancer by binding with LDHA.
Li H; Huang Q; Guo H; Chen X; Li X; Qiu M
Thorac Cancer; 2023 Feb; 14(4):389-398. PubMed ID: 36628612
[TBL] [Abstract][Full Text] [Related]
5. CircZBTB44 promotes renal carcinoma progression by stabilizing HK3 mRNA structure.
Li T; Gu Y; Xu B; Kuca K; Zhang J; Wu W
Mol Cancer; 2023 Apr; 22(1):77. PubMed ID: 37106446
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis.
Cen J; Liang Y; Huang Y; Pan Y; Shu G; Zheng Z; Liao X; Zhou M; Chen D; Fang Y; Chen W; Luo J; Zhang J
Mol Cancer; 2021 Jan; 20(1):19. PubMed ID: 33468140
[TBL] [Abstract][Full Text] [Related]
7. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
[TBL] [Abstract][Full Text] [Related]
8. LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription.
Xie X; Lin J; Fan X; Zhong Y; Chen Y; Liu K; Ren Y; Chen X; Lai D; Li X; Li Z; Tang A
Cell Death Dis; 2021 Feb; 12(2):201. PubMed ID: 33608495
[TBL] [Abstract][Full Text] [Related]
9. ZNF677 suppresses renal cell carcinoma progression through N6-methyladenosine and transcriptional repression of CDKN3.
Li A; Cao C; Gan Y; Wang X; Wu T; Zhang Q; Liu Y; Yao L; Zhang Q
Clin Transl Med; 2022 Jun; 12(6):e906. PubMed ID: 35678231
[TBL] [Abstract][Full Text] [Related]
10. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.
Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y
J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103
[TBL] [Abstract][Full Text] [Related]
11. A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR-567/ PRDX3 axis in renal cell carcinoma.
Yu R; Yao J; Ren Y
J Cell Mol Med; 2020 Sep; 24(17):10177-10188. PubMed ID: 32729669
[TBL] [Abstract][Full Text] [Related]
12. EGR2-mediated regulation of m
Ying Y; Ma X; Fang J; Chen S; Wang W; Li J; Xie H; Wu J; Xie B; Liu B; Wang X; Zheng X; Xie L
Cell Death Dis; 2021 Jul; 12(8):750. PubMed ID: 34326314
[TBL] [Abstract][Full Text] [Related]
13. CircARID1A binds to IGF2BP3 in gastric cancer and promotes cancer proliferation by forming a circARID1A-IGF2BP3-SLC7A5 RNA-protein ternary complex.
Ma Q; Yang F; Huang B; Pan X; Li W; Yu T; Wang X; Ran L; Qian K; Li H; Li H; Liu Y; Liang C; Ren J; Zhang Y; Wang S; Xiao B
J Exp Clin Cancer Res; 2022 Aug; 41(1):251. PubMed ID: 35986300
[TBL] [Abstract][Full Text] [Related]
14. m
Zhao Y; Zhou Y; Qian Y; Wei W; Lin X; Mao S; Sun J; Jin J
Clin Transl Med; 2024 Apr; 14(4):e1628. PubMed ID: 38572589
[TBL] [Abstract][Full Text] [Related]
15. CircNFATC3 promotes the proliferation of gastric cancer through binding to IGF2BP3 and restricting its ubiquitination to enhance CCND1 mRNA stability.
Yang F; Ma Q; Huang B; Wang X; Pan X; Yu T; Ran L; Jiang S; Li H; Chen Y; Liu Y; Liang C; Ren J; Zhang Y; Wang S; Li W; Xiao B
J Transl Med; 2023 Jun; 21(1):402. PubMed ID: 37340423
[TBL] [Abstract][Full Text] [Related]
16. IGF2BP3 mediates the mRNA degradation of NF1 to promote triple-negative breast cancer progression via an m6A-dependent manner.
Zhang X; Shi L; Sun HD; Wang ZW; Xu F; Wei JF; Ding Q
Clin Transl Med; 2023 Sep; 13(9):e1427. PubMed ID: 37743642
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA MYLK promotes tumour growth and metastasis via modulating miR-513a-5p/VEGFC signalling in renal cell carcinoma.
Li J; Huang C; Zou Y; Yu J; Gui Y
J Cell Mol Med; 2020 Jun; 24(12):6609-6621. PubMed ID: 32342645
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA Eps15-homology domain-containing protein 2 induce resistance of renal cell carcinoma to sunitinib via microRNA-4731-5p/ABCF2 axis.
Li W; Li G; Cao L
Bioengineered; 2022 Apr; 13(4):9729-9740. PubMed ID: 35412955
[TBL] [Abstract][Full Text] [Related]
19. MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma.
Du M; Peng Y; Li Y; Sun W; Zhu H; Wu J; Zong D; Wu L; He X
Cell Death Discov; 2022 Feb; 8(1):53. PubMed ID: 35136045
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma.
Liu Y; Cheng G; Huang Z; Bao L; Liu J; Wang C; Xiong Z; Zhou L; Xu T; Liu D; Yang H; Chen K; Zhang X
Cell Death Dis; 2020 Jul; 11(7):515. PubMed ID: 32641718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
